Related Experiment Video
Updated: May 12, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Congenital and perinatal cytomegalovirus lung infection
Eleonora Coclite1, Cecilia Di Natale, Giovanni Nigro
1Pediatric Unit and School of the University of L'Aquila, Maternal-Infant Department of San Salvatore Hospital , L'Aquila , Italy.
Insights
Cytomegalovirus (CMV) infection can cause severe lung disease in infants, particularly premature ones. Antiviral therapy
Area of Science:
- Neonatalogy
- Pediatric Pulmonology
- Infectious Diseases
Background:
- Cytomegalovirus (CMV) pneumonitis poses a significant threat, potentially leading to severe or fatal outcomes in infants with congenital or perinatal infections.
- Premature infants are particularly vulnerable to severe CMV lung disease.
Purpose of the Study:
- To comprehensively review the epidemiology, pathogenesis, clinical manifestations, and therapeutic strategies for prenatal and perinatal CMV-induced lung diseases in infants.
- To synthesize current knowledge on CMV pneumonitis in neonates.
Main Methods:
- Systematic evaluation of all published research articles on PubMed concerning CMV pneumonitis in infants.
- Literature review focusing on epidemiological, pathogenetic, clinical, and therapeutic aspects.
Main Results:
- CMV infection is prevalent and severe in immunosuppressed infants, less common in full-term neonates, and more frequent post-perinatal transmission, especially in premature infants.
- In premature infants, CMV infection often results in prolonged illness, diffuse interstitial pneumonitis, fibrosis, and bronchopulmonary dysplasia (BPD).
- Congenital CMV infection should be considered in neonates with severe respiratory distress, refractory respiratory failure, and progressing chronic lung disease; breast milk transmission is linked to cystic lung disease.
Conclusions:
- Persistent CMV infection can lead to diffuse necrotizing pneumonitis with fibrosis, ultimately causing BPD in both immunocompromised/preterm and, less commonly, immunocompetent infants.
- The efficacy of antiviral therapy for infant respiratory CMV diseases requires further investigation, as current data are limited to anecdotal reports.
Background:
Cytomegalovirus (CMV) pneumonitis may be severe, even lethal, following congenital infection or in premature infants with perinatal infection.
Objective:
To review the epidemiological, pathogenetic, clinical and therapeutic features of prenatal and perinatal CMV lung diseases.
Methods:
Evaluation of all published papers listed on PubMed describing CMV pneumonitis in infants.
Results:
CMV is frequent and severe in immunosuppressed infants but infrequent in full-term neonates and occurs more frequently after perinatal than after congenital infection, particularly in premature infants. In premature infants, CMV infection is often protracted and causes a diffuse interstitial pneumonitis leading to fibrosis and bronchopulmonary dysplasia (BPD). Congenital CMV infection should also be considered in newborns with severe acute respiratory distress syndrome and refractory respiratory failure with progression to early chronic lung disease. The association between breast milk-transmitted CMV and development of cystic lung disease and Wilson-Mikity syndrome has also been reported. Data on the efficacy of antiviral therapy for infants with respiratory CMV diseases are lacking and only anecdotal case reports are available.
Conclusions:
Persistent CMV infection appears to cause a diffuse necrotizing pneumonitis with fibrosis leading to BPD, in both immunocompromised or preterm infants and, less frequently in immunocompetent infants. The role of antiviral therapy remains to be elucidated.
More Related Videos
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Cytomegalovirus Disease
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pneumonia II: Pathophysiology
Encephalitis l: Introduction